Hilltop Partners’s iShares Biotechnology ETF IBB Stock Holding History

Hilltop Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,593	Closed	-$202K	–	122
2025 Q2	$202K	Sell	1,593 -95	-6%	-$11.7K	0.06%	113
2025 Q1	$216K	Sell	1,688 -14	-0.8%	-$1.9K	0.07%	98
2024 Q4	$225K	Sell	1,702 -10	-0.6%	-$1.41K	0.08%	94
2024 Q3	$249K	Hold	1,712	–	–	0.08%	91
2024 Q2	$235K	Hold	1,712	–	–	0.09%	88
2024 Q1	$235K	Sell	1,712 -6	-0.3%	-$819	0.08%	91
2023 Q4	$233K	Hold	1,718	–	–	0.09%	91
2023 Q3	$210K	Sell	1,718 -146	-8%	-$18.6K	0.09%	93
2023 Q2	$237K	Buy	1,864 +16	+0.9%	+$2.08K	0.1%	81
2023 Q1	$239K	Sell	1,848 -57	-3%	-$7.46K	0.11%	58
2022 Q4	$250K	Buy	+1,905	New	+$246K	0.13%	46

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hilltop Partners's IBB Position: Q3 2025 in Review

Hilltop Partners sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 1,593 shares — an estimated $202K sold.

Hilltop Partners first reported a position in IBB in Q4 2022 and held it in 11 quarters. The position peaked at $250K in Q4 2022. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Hilltop Partners reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Hilltop Partners sold 1,593 iShares Biotechnology ETF shares in Q3 2025, an estimated $202K.
Hilltop Partners first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 11 quarters.
Hilltop Partners's iShares Biotechnology ETF position peaked at $250K in Q4 2022.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Hilltop Partners's 13F filing for Q3 2025, filed 17 Nov 2025.